BBIO - BRIDGEBIO PHARMA INC
This page shows which of the focused investors we track hold BBIO and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2025 it was held by 2 managers with an aggregate reported value of $777.6M, which is 0.07% of the combined portfolio.
As of Q1 2025, 2 tracked institutional managers held BBIO (BRIDGEBIO PHARMA INC) with an aggregate reported value of $777.6M — 0.07% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BBIO — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2025
- Ticker
- BBIO
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Viking Global Investors - Viking Global Investors | 2.42% | Reduce -12.2% | 22,055,375 | $762.45M |
| 2 | Stanley Druckenmiller - Duquesne Family Office LLC | 0.51% | New | 438,050 | $15.14M |
Loading holder history for BBIO…